{
  "folder": "IC-191",
  "content": "{{knowledge objective\n|Identifiant=OIC-191-06-A\n|Item_parent=Fever in an immunocompromised patient\n|Item_parent_short=Fever in an immunocompromised patient\n|Rank=A\n|Item_parent_short=Fever in a febrile immunocompromised patient\n|Description=None\n|Rubric=Identification of urgency\n|Contributors=Am\u00e9lie Servettaz\n|Order=6}}\n\nFebrile neutropenia is \"always a therapeutic emergency\". Appropriate antibiotic therapy should be started as early as possible, after taking appropriate microbiological samples. Antibiotic therapy must be \"broad\" and \"adapted\" to the depth of neutropenia, its duration and the patient's risk factors, any clinical warning signs and \"previous microbiological documentation\" (e.g. carriage of multi-resistant bacteria, history of Pseudomonas infection, etc.).\n\nIn an immunocompromised patient, fever is always an emergency and an infectious agent must be sought, depending on the patient's deficiency (e.g. pneumococcal infection in a patient with a humoral deficiency, pulmonary pneumocystis in a patient with a cellular deficiency, etc.).",
  "question": {
    "properties": {
      "question": "In the management of febrile neutropenia in an immunocompromised patient, how should antibiotic therapy be administered?",
      "option_a": "Started immediately after identifying the specific bacterial agent causing the infection.",
      "option_b": "Broad and adapted to the depth of neutropenia, duration, patient's risk factors, clinical warning signs, and previous microbiological documentation.",
      "option_c": "Administered only after the fever has subsided for at least 24 hours to avoid unnecessary antibiotic use.",
      "option_d": "Delayed until the patient shows more severe symptoms to ensure targeted therapy.",
      "correct_option": "B"
    },
    "required": [
      "question",
      "option_a",
      "option_b",
      "option_c",
      "option_d",
      "correct_option"
    ]
  }
}